Skip to main content

Livforsakringsbolaget Skandia, Omsesidigt

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1547926 Stockholm, V7

Position in HALO

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$9,713,307
+$2,209,764 QoQ
Shares Held
124,100
+6.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#119
of 666 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Livforsakringsbolaget Skandia, Omsesidigt holds $40,172,931 across 9 Biotechnology names. HALO ranks #3 (24.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 HALO
Halozyme Therapeutics, Inc.
This page
124,100 $9,713,307

All Filings in HALO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,713,307 124,100
2026-03-31 $7,503,543 116,100
2025-12-31 $7,059,770 104,900
2025-09-30 $7,693,366 104,900
2025-06-30 $5,306,040 102,000
2025-03-31 $3,656,313 57,300
2024-12-31 $2,739,513 57,300
2024-09-30 $3,279,852 57,300
2024-06-30 $2,413,796 46,100
2024-03-31 $215,604 5,300
2023-12-31 $195,888 5,300